How Does Classic CAH Affect Adult Height and Bone Age?

A common and understandable concern for parents of a child with classic Congenital Adrenal Hyperplasia (CAH) is whether their child will be unusually short as an adult. The short answer is that while children with classic CAH can absolutely reach a normal adult height, they often end up slightly shorter than what would be predicted based on their parents’ heights (their midparental height estimate) ^[1][2]. Maximizing a child’s adult height requires a delicate, ongoing balance by your pediatric endocrinologist to avoid both undertreatment and overtreatment.

The Balancing Act: Undertreatment vs. Overtreatment

Treating classic CAH involves replacing the cortisol the body cannot make using a glucocorticoid medication, such as hydrocortisone. (Many children also need a mineralocorticoid, like fludrocortisone, for salt and blood-pressure balance, but glucocorticoids are the primary medications that affect growth). Providing the right amount of hydrocortisone stops the adrenal glands from overproducing adrenal androgens (hormones that can promote male-typical physical changes, though they are naturally present in everyone).

Finding the exact right dose is complex because both too little and too much medication can negatively impact your child’s final adult height.

The Risks of Undertreatment

When a child does not receive enough glucocorticoid medication, their body continues to overproduce adrenal androgens ^[3].

• Early Growth Spurt and Premature Fusion: Excess androgens cause a child to grow very quickly early on, often making them taller than their peers during early childhood ^[4]. However, these hormones also cause the skeleton to mature too fast ^[4]. This causes the growth plates (the areas of new bone growth) to close prematurely, halting linear growth sooner than normal and resulting in a shorter adult height ^[1].
• Early Physical Changes and Puberty: High levels of adrenal androgens can trigger early physical signs like body odor, acne, and pubic hair ^[5]. Over time, this androgen exposure can also trigger true central precocious puberty—meaning the brain signals the body to start full pubertal development (like breast development or testicular enlargement) too early ^[5]. Once puberty finishes, growth stops, limiting the time the child has to reach their full height.

The Risks of Overtreatment

To completely suppress excess androgens, a child might require higher doses of glucocorticoids. However, overtreating with these medications carries its own severe risks.

• Stunted Growth: Supraphysiologic doses (medication doses higher than what the body naturally needs to replace missing cortisol) directly impair bone growth and slow down how fast the child is growing ^[6][7].
• Weight Gain and Cushing Syndrome: Overtreatment can cause excessive weight gain and symptoms of iatrogenic Cushing syndrome (side effects from excess steroids, such as a rounded face and altered body fat distribution), which further complicates healthy development ^[6][7].

Because of these combined risks, doctors generally avoid trying to force lab tests into completely “normal” ranges if doing so requires excessive steroid medication ^[8].

Why Bone Age Matters

Because blood tests alone don’t tell the whole story, pediatric endocrinologists rely heavily on bone age X-rays ^[9]. A bone age study is a quick, simple X-ray of the child’s left hand and wrist.

The doctor compares the appearance of the child’s bones to standard age-based images to determine their “bone age” and estimate how much growing time is left before the growth plates close ^[9].

• If the bone age is significantly advanced (older than the child’s chronological age), it means skeletal maturation is happening too quickly, usually due to excess androgens from undertreatment ^[1][9].
• Research shows that advanced bone age in childhood is associated with a shorter final adult height ^[1].

By routinely monitoring bone age—on a schedule individualized to your child’s specific growth patterns—your care team can estimate remaining growth potential and adjust treatments accordingly. Keep in mind, however, that bone age provides an estimate, not a guaranteed forecast of final height.

How Endocrinologists Protect Your Child’s Growth

Maximizing adult height isn’t just about achieving a specific lab number; it’s about evaluating the whole child. Pediatric endocrinologists use a combination of tools to guide their decisions:

• Growth Tracking: Doctors track height velocity (how fast the child is growing) and body weight at every visit ^[10].
• Bone Age Scans: Used to estimate remaining growth potential and catch early signs of premature skeletal maturation ^[9].
• Biomarkers: Blood or urine tests for 17-OHP and androstenedione help show how well the medication is controlling the adrenal glands ^[10]. However, these hormone levels change drastically throughout the day based on when the last medication dose was given ^[11]. A single mildly elevated 17-OHP level is often accepted to avoid overtreatment, provided the child is growing normally ^[8].

Crucial Warning: You must never adjust your child’s medication doses based on a single lab result, a sudden growth spurt, or a slowdown in height. Unplanned changes to glucocorticoids can be dangerous. Always rely on your endocrinology team to interpret these complex, interconnected signs and make safe adjustments.

Safety Note: Preventing Adrenal Crisis
While managing growth is important, the most critical aspect of CAH care is preventing a life-threatening adrenal crisis. Missed doses of hydrocortisone are dangerous. If your child is sick, vomiting, or unable to retain their medication, you must follow your individualized sick-day stress dosing plan. Always keep emergency injectable hydrocortisone readily available, ensure your child wears medical-alert identification, and seek urgent emergency care if they exhibit severe weakness, vomiting, dehydration, or confusion.